CDER New February 3, 2017

What's New on the FDA Drugs Site

February 2, 2017

• Public Notifications:
  • Goldreallas XXX Contains Hidden Drug Ingredient
  • Old Chinese Contains Hidden Drug Ingredient
  • Shenjingpian Contains Hidden Drug Ingredient
  • Lean Extreme Max Contains Hidden Drug Ingredient
  • X-treme Beauty Slim Contains Hidden Drug Ingredient
• Selected Presentations by OMQ Leaders (updated)
• CDER Small Business and Industry Education Series: Best Practices for Communication Between FDA and IND Sponsors During Drug Development 
  The course describes best practices and procedures for timely, transparent, and effective communications between investigational new drug application (IND) sponsors and FDA at critical junctures in drug development. 
• Drug Firm Annual Registration Status Download File (updated)
• Drug Firm Annual Registration Status (updated)
• FDA Drug Safety Communication: FDA warns about rare but serious allergic reactions with the skin antiseptic chlorhexidine gluconate
• National Drug Code Directory 
• Postmarket Requirements and Commitments Search
• Postmarket Requirements and Commitments: Downloadable Database File
• Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)